Symbol="MORF"
AssetType="Common Stock"
Name="Morphic Holding Inc"
Description="Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small molecule integrin therapies for the treatment of autoimmune, cardiovascular, metabolic, fibrosis, and cancer diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1679363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="35 GATEHOUSE DRIVE A2, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2541929000"
EBITDA="-69930000"
PERatio="None"
PEGRatio="None"
BookValue="10.76"
DividendPerShare="0"
DividendYield="0"
EPS="-1.62"
RevenuePerShareTTM="1.774"
ProfitMargin="-0.924"
OperatingMarginTTM="-1.029"
ReturnOnAssetsTTM="-0.106"
ReturnOnEquityTTM="-0.172"
RevenueTTM="68947000"
GrossProfitTTM="-31254000"
DilutedEPSTTM="-1.62"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.781"
AnalystTargetPrice="74"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="14.03"
PriceToBookRatio="2.901"
EVToRevenue="9.32"
EVToEBITDA="-12.06"
Beta="1.104"
num_52WeekHigh="63.08"
num_52WeekLow="23.03"
num_50DayMovingAverage="58.06"
num_200DayMovingAverage="40.25"
SharesOutstanding="45825300"
DividendDate="None"
ExDividendDate="None"
symbol="MORF"
open="55.48"
high="56.40"
low="54.83"
price="55.48"
volume="250252.00"
latest_trading_day="2023-07-25"
previous_close="55.47"
change="0.01"
change_percent="0.0180%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="547996"
Change_recent_avg="-0.06"
Delta_recent_avg="2.46"
Variance_recent_avg="1.23"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="97"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_negative_thumbnail_id_2="1120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="683"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_positive_thumbnail_id_2="998"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
